Dose Chex
10
Quality Score
Niche
Dose Chex
Low confidence
✍️ bumetric analysis
“
Dose Chex is an iOS app from Lindum Medical Ltd in the Education category, currently rated 1.0★ across 1 ratings. Initial signal reads as mostly critical sentiment so far: users flag rough edges and unmet expectations.
Quality Score is 10: Niche (micro-niche or pre-traction stage). For a Education app, that means micro-niche or pre-traction stage. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Monthly revenue · now vs forecast
● Right now
$562
per month
→
12-mo forecast
$491 – $1771
per month
→
24-mo forecast
$455 – $4097
per month
INDIE tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
ONE-TIME · BUILD
💰 Estimated build cost
$60K
↳ What it cost to build · not monthly revenue
Likely range $45K – $80K
$25K · MVP floor
$100K · indie scale
$500K+ · studio build
📈
Slow ROI — current MRR is well below build cost
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
Where the money goes
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| ⚙ Education complexity ×1.20 | +$10K |
Total estimate
$60K
🔬
How we forecast this revenue
LOW CONFIDENCEBaseline
$562/mo · ML-estimated from 234 triggers
Growth rate
+6.0% MoM · INDIE tier baseline (compound monthly)
Direction
Headwinds: rating drift may slow acquisition
6 months
$478 – $1.1K
12 months
$491 – $1.8K
24 months
$455 – $4.1K
Compound growth at +6.0% MoM (tier baseline for INDIE). Range widens with horizon — typical noise band ±40% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Pre-traction · 31/100INDIE TIERlimited signalGrowth Velocity
5.0
Founder Strength
3.7
Product Quality
0.8
Revenue Strength
2.7
Monetization Maturity
1.0
Defensibility
4.2
Market Position
2.0
Operational Safety
5.0
- 💰 Revenue: Marginal — $224 - $1405/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: 1.0★ across 1 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: ⚠ last update 503d ago — possibly dormant.
- ⚠️ Risk: Elevated — dormant (503d since update).
🎯 For competitors: Vulnerable. Quality drift + slow updates create a clear opening for a fresh competitor with active dev cadence.
💵 For acquirers: Estimated asking range 18-32× monthly = $10K-$17K.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 5 of 5 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| Paid app ($0.00)METRIC | +$2,800 | |
| Below-average rating (1.0★)METRIC | −$1,500 | |
| Mature app (8y old)METRIC | +$1,500 | |
| Single-language (English only)METRIC | −$400 | |
| Pre-traction phase (1 ratings)METRIC | −$300 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
🆕 What's New · v3.0
This version adds improved ability to order the lists of medications and now includes the ability to convert weights directly from the drug calculation.
There have been improvements to the user interface and minor bug fixes.
There have been improvements to the user interface and minor bug fixes.
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- Dose Chex
- Developer
- Lindum Medical Ltd
- Bundle ID
- Not found
- App Store URL
- Open in App Store
- Category
- Education
- Content rating
- 12+
- Languages
- EN
Company
- Website
- Not found
- Tagline
- Today
- Description
- Find apps and games for iPhone, iPad, Mac, and more on the App Store.
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Available
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $459/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
Contacts & Socials data not yet collected for this app.
📈Ratings growth1 ratingsShow 3-year history estimate ▾
Tracked (10 weeks) Pre-tracking estimate (36 weeks) · model-based, ±5% noise · anchored to release date and current value
🌍Geographic ReachNot ranked
This app is currently outside the top 100 grossing in all 9 countries we monitor (US, UK, DE, FR, JP, CA, AU, BR, IN). Niche or new apps often launch this way — popularity rankings appear once daily revenue clears the regional threshold.
💰Pricing History$0.00 → $1.99 (+0%)
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
📝 About this app
Dose Chex is designed to simplify the calculations required when administering drugs and fluids. Rather than performing drug calculations manually, Dose Chex performs them for you. It is fast and reliable, and won’t be affected by working a long shift!
You can create different medications as required and save them for future calculations. A number of safety features highlight potential sources of error, such as using the incorrect units.
The app can be customised to eliminate potential sources of error.… View full description on the official store →
You can create different medications as required and save them for future calculations. A number of safety features highlight potential sources of error, such as using the incorrect units.
The app can be customised to eliminate potential sources of error.… View full description on the official store →
App Specs
🔐 Own this app? Claim & verify MRR →💾 3 MB🔞 12+📱 iOS 16.0+🔖 v3.0🔄 updated 0d ago🌐 EN📂 Education💰 Paid
📅
What Worked™ · Development Pipeline
2 EVENTS TRACKEDDetected changes in this app over its tracked lifetime — each event links cause (what changed) to effect (what moved). Sorted newest first.See full history →Version history →
2026-03
⭐
Rating ↓ 1.38 → 1.00 (dropped 0.38★)
2019-09
🚀
First tracked snapshot — initial data captured
🌍
Multi-Country Performance
Available in 9 of 9 monitored markets| Market | Rating | Reviews | Current version |
|---|---|---|---|
| 🇦🇺 AU | 0★ | 0 | — |
| 🇧🇷 BR | 0★ | 0 | — |
| 🇨🇦 CA | 0★ | 0 | — |
| 🇩🇪 DE | 0★ | 0 | — |
| 🇫🇷 FR | 0★ | 0 | — |
| 🇬🇧 GB | 1★ | 1 | 1★ this version |
| 🇮🇳 IN | 0★ | 0 | — |
| 🇯🇵 JP | 0★ | 0 | — |
| 🇺🇸 US | 5★ | 1 | 5★ this version |
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
📝 Description
95
BU Score · Transcendent
About this analysis
Why low confidence: only 1 rating · no founder-verified revenue (model estimate only) · revenue figure is directional only.
📌 Final verdict — read this before you trust the numbers above
Dose Chex is a very early-stage iOS app in the education space with weak public traction — only 1 rating, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.
Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.
❓ Frequently Asked Questions
4 answers · auto-generated from this app's public dataHow much does Dose Chex make per month?▴
Low-confidence model estimate. Dose Chex has only 1 App Store rating, so our revenue model has very little signal to work with — treat the ~$459/mo figure as directional only, not a verified MRR. No founder-verified revenue data is available for this app. See methodology for the formula and confidence bands.
What apps are like Dose Chex?▴
Browse the full Education category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
Who makes Dose Chex?▴
Dose Chex is published by Lindum Medical Ltd on the Apple App Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is Dose Chex's BU Score?▴
Dose Chex has a BU Score of 10/100 (Niche). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.